Clinical Trial Update: Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant chemotherapy plus camrelizumab for FIGO stage IB1 cervical cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: Tongji Hospital | Conditions: Cervical Cancer, Neoadjuvant Chemoimmunotherapy | Phase 2 | Status: RECRUITING